Monographie - Rolapitant

Poslední aktualizace :
08/05/2024

Rolapitant

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Varubi

Jungtinės Amerikos Valstijos

Mišinių stabilumas : Rolapitant

1,65 mg/ml

Rolapitant
Palonosetron hydrochloride	2,28 µg/ml

2-8°C

3928

1,83 mg/ml

Rolapitant
Granisetron hydrochloride	0,01 mg/ml

2-8°C

4061

1,6 mg/ml

Rolapitant
Palonosetron hydrochloride	2,1 µg/ml
Dexamethasone sodium phosphate	0,178 mg/ml

2-8°C

4062

1,6 mg/ml

Rolapitant
Palonosetron hydrochloride	2,1 µg/ml
Dexamethasone sodium phosphate	0,093 mg/ml

2-8°C

4062

1,65 mg/ml

Rolapitant
Palonosetron hydrochloride	2,28 µg/ml

20-25°C

3928

1,7 mg/ml

Rolapitant
Dexamethasone sodium phosphate	0,086 mg/ml

20-25°C

3927

1,7 mg/ml

Rolapitant
Dexamethasone sodium phosphate	0,170 mg/ml

20-25°C

3927

1,83 mg/ml

Rolapitant
Granisetron hydrochloride	0,01 mg/ml

20-25°C

4061

1,6 mg/ml

Rolapitant
Palonosetron hydrochloride	2,1 µg/ml
Dexamethasone sodium phosphate	0,093 mg/ml

20-25°C

4062

1,6 mg/ml

Rolapitant
Palonosetron hydrochloride	2,1 µg/ml
Dexamethasone sodium phosphate	0,178 mg/ml

20-25°C

4062

1,65 mg/ml

Rolapitant
Palonosetron hydrochloride	2,28 µg/ml

2-8°C

3928

1,65 mg/ml

Rolapitant
Palonosetron hydrochloride	2,28 µg/ml

20-25°C

3928

1,7 mg/ml

Rolapitant
Dexamethasone sodium phosphate	0,170 mg/ml

20-25°C

3927

1,7 mg/ml

Rolapitant
Dexamethasone sodium phosphate	0,086 mg/ml

20-25°C

3927

Mentions Légales